tradingkey.logo
搜索

Vivos Therapeutics Inc

VVOS
添加自选
0.453USD
-0.045-9.05%
收盘 07/02, 13:00美东报价延迟15分钟
4.21M总市值
亏损市盈率 TTM

Vivos Therapeutics Inc

0.453
-0.045-9.05%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-9.05%

5天

+1.25%

1月

-34.56%

6月

-82.09%

今年开始到现在

-77.67%

1年

-89.77%

关键数据
0.483今开
0.508最高
400.62K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
4.31%换手率
0.498昨收
0.445最低
115.58K成交额
亏损市盈率静
-2.82市净率
0.00%股息率 TTM
-138.29%ROA
7.95052周最高
0.23量比
-11.14M净利润
9.29M总股本
-2.1360每股收益TTM
6.09Beta
-1528.79%ROE
0.54552周最低
12.70%振幅
50.67%毛利率
4.21M总市值
-4.64回报/风险
6.05%风险率

TradingKey Vivos Therapeutics Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Vivos Therapeutics Inc当前公司基本面数据相对谨慎,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名133/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.45。中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Vivos Therapeutics Inc评分

相关信息

行业排名
133 / 204
全市场排名
324 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Vivos Therapeutics Inc亮点

亮点风险
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
业绩高增长
公司营业收入稳步增长,连续3年增长26.39%
业绩增长期
公司处于发展阶段,最新年度总收入17.44M美元
利润高增长
公司净利润处于行业前列,最新年度总收入17.44M美元
估值高估
公司最新PE估值-0.21,处于3年历史高位
机构减仓
最新机构持股1.10M股,环比减少6.15%
活跃度增加
近期活跃度增加,过去20天平均换手率5.05

分析师目标

根据 3 位分析师
买入
评级
2.450
目标均价
+391.67%
涨幅空间

Vivos Therapeutics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Vivos Therapeutics Inc简介

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
公司代码VVOS
公司Vivos Therapeutics Inc
CEOHuntsman (R. Kirk)
网址https://vivos.com/

常见问题

Vivos Therapeutics Inc(VVOS)的当前股价是多少?

Vivos Therapeutics Inc(VVOS)的当前股价是 0.45。

Vivos Therapeutics Inc的股票代码是什么?

Vivos Therapeutics Inc的股票代码是VVOS。

Vivos Therapeutics Inc股票的52周最高点是多少?

Vivos Therapeutics Inc股票的52周最高点是7.95。

Vivos Therapeutics Inc股票的52周最低点是多少?

Vivos Therapeutics Inc股票的52周最低点是0.55。

Vivos Therapeutics Inc的市值是多少?

Vivos Therapeutics Inc的市值是4.21M。

现在Vivos Therapeutics Inc(VVOS)的股票是买入、持有还是卖出?

根据分析师评级,Vivos Therapeutics Inc(VVOS)的总体评级为买入,目标价格为2.45。

Vivos Therapeutics Inc(VVOS)股票的每股收益(EPS TTM)是多少

Vivos Therapeutics Inc(VVOS)股票的每股收益(EPS TTM)是-2.06。